Inside Epic’s Rapid-Fire Research Machine
Physicians at the University of Florida noticed an uptick in sinus infections after hurricanes and turned to Epic…
EU Reform Aims to Fast-Track Cancer Drug Access
At the European Society for Medical Oncology (ESMO) Annual Meeting 2025, held recently in Berlin, experts presented an…
Tip Sheet: How patient advocacy shapes research and care, how HIV/AIDS research benefits other diseases — and invasive lobular breast cancer awareness
SEATTLE — Nov. 4, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
FDA approves new menopause drug without hormones. Here’s what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker…
Novartis Cosentyx® meets primary and all secondary endpoints in Phase III trial in patients with polymyalgia rheumatica (PMR)
Cosentyx® (secukinumab) achieved statistically significant and clinically meaningful sustained remission vs placebo at Week 521Trial showed reduction in…
Largest-ever £26 million trial launches across UK to slow Parkinson’s disease
Image: ©Naeblys | iStock The world’s largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments…
New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
Common opioid is not that effective for easing chronic pain, study finds
Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
US Health Secretary Kennedy speeds autism drug with GSK help
By Patrick Wingrove, Maggie Fick and Julie Steenhuysen (Reuters) -U.S. Health Secretary Robert F Kennedy Jr. could deliver…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICO
Joint debt: Let’s see Draghi has been a consistent advocate for EU joint borrowing of the kind carried…